Skip to Content

GMO Benchmark-Free Allocation IV GBMBX

Medalist Rating as of | See GMO Investment Hub
  • NAV / 1-Day Return 26.33  /  −0.19 %
  • Total Assets 2.6 Bil
  • Adj. Expense Ratio
    1.110%
  • Expense Ratio 1.110%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Global Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 5.53%
  • Turnover 19%

USD | NAV as of Apr 15, 2024 | 1-Day Return as of Apr 15, 2024, 11:36 PM GMT+0

Morningstar’s Analysis GBMBX

Will GBMBX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A consistently contrarian approach that requires patience.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark-Free Allocation packages the firm’s contrarian views and value-driven asset-class forecasts. The differentiated approach is consistently applied by a research-focused team, but it can face prolonged periods of underperformance.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GBMBX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 3.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United States Treasury Notes 1.375%

6.12 236.6 Mil
Government

United States Treasury Notes

5.10 197.1 Mil
Government

FHLBA

3.12 120.6 Mil
Government

United States Treasury Notes 1.25%

2.94 113.8 Mil
Government

United States Treasury Notes

2.61 100.9 Mil
Government

United States Treasury Notes

2.35 90.9 Mil
Government

United States Treasury Notes

1.53 59.3 Mil
Government

United States Treasury Notes

1.42 55.0 Mil
Government

United States Treasury Notes

1.29 49.7 Mil
Government

Dummygmo Benchmark-Free Allocation Strategy

−19.98 −773.0 Mil